Enoxaparin Sodium Injection — FDA Drug Shortage

To Be Discontinued — Sanofi-Aventis U.S. LLC

The FDA lists a drug shortage record for Enoxaparin Sodium Injection (injection) from Sanofi-Aventis U.S. LLC with status To Be Discontinued. The shortage was first posted on Oct 20, 2026.

Shortage details

Status
To Be Discontinued
Company
Sanofi-Aventis U.S. LLC
Package NDC
0075-0623-00
Dosage Form
Injection
Presentation
Lovenox, Injection, 100 mg/1 mL (NDC 0075-0623-00)
Initial Posting
Oct 20, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.